Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02354742 · ClinicalTrials.gov registry record · NA
Echo vs. EGDT in Severe Sepsis and Septic Shock
A NA study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02354742 is a NA study that has completed, run by Intermountain Health Care. The registered enrollment target is 80 participants.
The verdict
NCT02354742, a NA study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Echocardiography (cardiac ultrasound) is being used more often in the critical care setting for management of severe infection (septic shock). Early studies show echocardiography to be useful in these patients, but at this time, there are no good clinical trials to justify its use. Our study goals/objectives are as follows: 1. To conduct an unblinded, two-group randomized controlled clinical trial to compare an echocardiography-guided resuscitation protocol with an Early Goal Directed Therapy (EGDT) protocol in patients with severe sepsis or septic shock. 2. Demonstrate that a sepsis treatment protocol using transthoracic echocardiography and other non-invasive assessments of cardiac output will result in more rapid resolution of septic shock compared to invasive EGDT. 3. Demonstrate patients receiving the non-invasive echocardiography protocol will receive less administration of intravenous fluid.
Interventions
- OTHER Echo guided fluid resuscitation
- OTHER EGDT fluid resuscitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02354742
The ClinicalTrials.gov registry entry for NCT02354742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Echo guided fluid resuscitation is the first listed.
NCT02354742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02354742 about?
NCT02354742 is a clinical study titled "Echo vs. EGDT in Severe Sepsis and Septic Shock". Echocardiography (cardiac ultrasound) is being used more often in the critical care setting for management of severe infection (septic shock). Early studies show echocardiography to be useful in these patients, but at this time, there are no good clinical trials to justify its use. Our study goals/...
What is the current status of trial NCT02354742?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2014-12. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02354742?
The interventions under investigation include: Echo guided fluid resuscitation (OTHER), EGDT fluid resuscitation (OTHER).
Who is sponsoring clinical trial NCT02354742?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.